{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:26:45Z","timestamp":1781634405806,"version":"3.54.5"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0224130","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T17:43:34Z","timestamp":1571679814000},"page":"e0224130","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma: A\u00a0preclinical F98 glioblastoma rat model study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2204-6056","authenticated-orcid":true,"given":"Valerie","family":"De Meulenaere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Bonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-7760","authenticated-orcid":true,"given":"Jeroen","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Kalala Okito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"De Wever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Leybaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Goethals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Vanhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8879-1772","authenticated-orcid":true,"given":"Benedicte","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Deblaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"pone.0224130.ref001","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"DN Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"pone.0224130.ref002","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"DN Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"pone.0224130.ref003","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and Other Malignant Gliomas.","volume":"310","author":"A Omuro","year":"2013","journal-title":"Jama"},{"key":"pone.0224130.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-12048-5_1","volume":"163","author":"QT Ostrom","year":"2015","journal-title":"Epidemiology of Gliomas. Cancer Treat Res"},{"key":"pone.0224130.ref005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1148\/radiology.152.3.6463251","article-title":"Comparison of CT and MR in 400 patients with suspected disease of the brain and cervical spinal cord","volume":"152","author":"WG Bradley","year":"2014","journal-title":"Radiology"},{"key":"pone.0224130.ref006","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. Supplemental information","volume":"352","author":"R Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"pone.0224130.ref007","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2015.06.137","article-title":"Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine","volume":"468","author":"S-SS Kim","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"pone.0224130.ref008","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.coph.2018.05.002","article-title":"Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics","volume":"41","author":"CL Grek","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"pone.0224130.ref009","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/cdd.2008.196","article-title":"Connexin-related signaling in cell death: To live or let die","volume":"16","author":"E Decrock","year":"2009","journal-title":"Cell Death Differ"},{"key":"pone.0224130.ref010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature16071","article-title":"Brain tumour cells interconnect to a functional and resistant network","volume":"528","author":"M Osswald","year":"2015","journal-title":"Nature"},{"key":"pone.0224130.ref011","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1593\/neo.10602","article-title":"Reactive Astrocytes Protect Melanoma Cells from Chemotherapy by Sequestering Intracellular Calcium through Gap Junction Communication Channels","volume":"12","author":"Q Lin","year":"2010","journal-title":"Neoplasia"},{"key":"pone.0224130.ref012","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature18268","article-title":"Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer","volume":"533","author":"Q Chen","year":"2016","journal-title":"Nature"},{"key":"pone.0224130.ref013","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s13311-017-0536-9","article-title":"Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels","volume":"14","author":"Y Kim","year":"2017","journal-title":"Neurotherapeutics"},{"key":"pone.0224130.ref014","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1474-4422(09)70135-8","article-title":"Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study","volume":"8","author":"AW Hauge","year":"2009","journal-title":"Lancet Neurol"},{"key":"pone.0224130.ref015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11060-009-9875-7","article-title":"Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas","volume":"94","author":"RF Barth","year":"2009","journal-title":"J Neurooncol"},{"key":"pone.0224130.ref016","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00688846","article-title":"Morphological characterization of nitrosourea-induced glioma cell lines and clones","volume":"51","author":"L Ko","year":"1980","journal-title":"Acta Neuropathol"},{"key":"pone.0224130.ref017","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-014-1552-9","article-title":"MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform","volume":"120","author":"J Bolcaen","year":"2014","journal-title":"J Neurooncol"},{"key":"pone.0224130.ref018","first-page":"1","article-title":"Technical feasibility of [18 F ] FET and [18 F ] FAZA PET guided radiotherapy in a F98 glioblastoma rat model","author":"J Verhoeven","year":"2019"},{"key":"pone.0224130.ref019","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/onc.2015.210","article-title":"Astrocytes promote glioma invasion via the gap junction protein connexin43","volume":"35","author":"WC Sin","year":"2015","journal-title":"Oncogene"},{"key":"pone.0224130.ref020","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.bbamem.2011.10.022","article-title":"Opposing roles of connexin43 in glioma progression","volume":"1818","author":"W Sin","year":"2012","journal-title":"BBA\u2014Biomembr"},{"key":"pone.0224130.ref021","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1158\/0008-5472.CAN-15-1286","article-title":"Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide","volume":"76","author":"SF Murphy","year":"2015","journal-title":"Cancer Res"},{"key":"pone.0224130.ref022","first-page":"295","article-title":"Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43-mediated gap junction intercellular communication","volume":"52","author":"L Wang","year":"2018","journal-title":"Int J Oncol"},{"key":"pone.0224130.ref023","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuropharm.2013.05.002","article-title":"Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway","volume":"75","author":"PR Gielen","year":"2013","journal-title":"Neuropharmacology"},{"key":"pone.0224130.ref024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2014.111","article-title":"Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor- mediated induction of connexin 43","volume":"5","author":"JL Munoz","year":"2014","journal-title":"Cell Death Dis"},{"key":"pone.0224130.ref025","doi-asserted-by":"crossref","first-page":"86406","DOI":"10.18632\/oncotarget.13415","article-title":"Patient-derived glioblastoma stem cells respond differentially to targeted therapies","volume":"7","author":"P Kanabur","year":"2016","journal-title":"Oncotarget"},{"key":"pone.0224130.ref026","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/10717544.2010.549527","article-title":"Visualization of Connexin 43-positive cells of glioma and the periglioma zone by means of intravenously injected monoclonal antibodies","volume":"18","author":"VP Baklaushev","year":"2011","journal-title":"Drug Deliv"},{"key":"pone.0224130.ref027","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10517-014-2603-0","article-title":"Treatment of Poorly Differentiated Glioma Using a Combination of Monoclonal Antibodies to Extracellular Connexin-43 Fragment, Temozolomide, and Radiotherapy","volume":"157","author":"GM Yusubalieva","year":"2014","journal-title":"Bull Exp Biol Med"},{"key":"pone.0224130.ref028","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc.2016.105","article-title":"Gap Junctions and Cancer: Communicating for 50 Years.","volume":"16","author":"T Aasen","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"pone.0224130.ref029","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1038\/s41388-019-0741-6","article-title":"Connexins in cancer: bridging the gap to the clinic","volume":"38","author":"T Aasen","year":"2019","journal-title":"Oncogene"},{"key":"pone.0224130.ref030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrc2841","article-title":"Implications and challenges of connexin connections to cancer","volume":"10","author":"CC Naus","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"pone.0224130.ref031","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nrd.2018.138","article-title":"Therapeutic strategies targeting connexins","volume":"17","author":"DW Laird","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"pone.0224130.ref032","first-page":"683","article-title":"Changes in blood-brain barrier permeability induced by radiotherapy: Implications for timing of chemotherapy? (Review).","volume":"9","author":"M Van Vulpen","year":"2002","journal-title":"Oncol Rep"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0224130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T18:19:31Z","timestamp":1611598771000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0224130"}},"subtitle":[],"editor":[{"given":"Jonathan H.","family":"Sherman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0224130","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,21]]}}}